Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02693145 · ClinicalTrials.gov registry record · NA
Cooperative Re-Engagement Controlled Trial (CoRECT)
A NA study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- NA
- Development phase
- 1,893
- Enrollment target
NCT02693145 is a NA study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 1,893 participants.
The verdict
NCT02693145, a NA study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,893 participants
- Enrollment target
Study Summary
CoRECT will help identify the important components of a data-sharing partnership between health departments and HIV care providers, and determine the extent to which a health department intervention can increase the number of HIV-infected persons out-of-care who: (a) link to an HIV clinic; (b) remain in HIV medical care; (c) achieve HIV viral load suppression within 12 months; and (d) achieve durable HIV viral load suppression over 18 months. We will also measure the cost-effectiveness of this intervention in regards to improved health in the individuals (re)-engaged in HIV care and reductions in further HIV transmission in the community.
Interventions
- OTHER Anti-Retroviral Treatment and Access to Services (ARTAS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,893 participants |
| Start Date | 2016-08 |
| Est. Completion | 2020-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02693145
The ClinicalTrials.gov registry entry for NCT02693145 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,893 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Anti-Retroviral Treatment and Access to Services (ARTAS) is the first listed.
NCT02693145 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02693145 about?
NCT02693145 is a clinical study titled "Cooperative Re-Engagement Controlled Trial (CoRECT)". CoRECT will help identify the important components of a data-sharing partnership between health departments and HIV care providers, and determine the extent to which a health department intervention can increase the number of HIV-infected persons out-of-care who: (a) link to an HIV clinic; (b) remai...
What is the current status of trial NCT02693145?
This trial is currently completed. It is a NA study. The enrollment target is 1,893 participants. The study started on 2016-08. Estimated completion is 2020-08.
What interventions are being tested in trial NCT02693145?
The interventions under investigation include: Anti-Retroviral Treatment and Access to Services (ARTAS) (OTHER).
Who is sponsoring clinical trial NCT02693145?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.